CERMEP - imagerie du vivant

At CERMEP - imagerie du vivant, clinical research in this area focuses on diagnostic imaging and the evaluation of biological markers linked to Parkinson disease. The studies are designed to better understand how brain receptors and signaling systems change in people with neurological disease, supporting more precise detection and interpretation of early abnormalities.

• Testing imaging-based approaches to measure the 5-HT4 receptor in Parkinson's disease
• Using advanced brain imaging to explore early changes in the serotoninergic system
• Comparing findings in patients and healthy controls to improve diagnostic insight

These trials aim to refine how neurological disorders are identified and characterized, with a particular emphasis on imaging tools that can reveal subtle disease-related changes.

This research site is also active in nervous system disease studies centered on Parkinson disease and its early stages. The work examines how brain chemistry is affected before and after clear symptoms appear, helping researchers learn more about disease development and progression.

• Studying Parkinson's disease in people with mild to moderate symptoms
• Investigating the prodromal phase of Parkinson's disease in individuals carrying SNCA gene mutations
• Assessing whether brain imaging can detect early neurological changes linked to disease onset

The main purpose is to improve understanding of disease mechanisms and support earlier recognition of Parkinsonian disorders before they fully develop.

Clinical trials at CERMEP also address pathological conditions associated with movement and brain function, focusing on symptoms and underlying changes that may appear during the course of Parkinson's disease. This line of research helps connect clinical features with measurable biological alterations.

• Exploring symptom-related brain changes in people with Parkinson disease
• Evaluating early abnormalities that may precede visible motor symptoms
• Linking clinical presentation with serotonergic system impairment

These studies are intended to improve the interpretation of disease signs and support better clinical assessment of patients at different stages of illness.

Research in this therapeutic area examines how musculoskeletal and neural physiological processes are altered in Parkinson's disease. By observing brain system activity in both affected participants and healthy controls, the trials seek to clarify how movement-related biology shifts as the disease emerges and evolves.

• Investigating changes in brain physiology during the prodromal stage of disease
• Comparing neural signaling patterns between patients and control participants
• Studying how early biological changes may relate to later motor impairment

The research is aimed at understanding the physiological pathways involved in Parkinsonian disorders and identifying changes that could support earlier intervention.